FinTechFunding

BTC Health: Investee gains NEOLA distribution rights

  • BTC Health (BTC) investee BioImpact has won exclusive rights to distribute the NEOLA device in Australia, New Zealand and Singapore
  • NEOLA is a non-invasive medical device to measure volume changes and oxygen concentration in the lungs of preterm infants
  • This allows health care professionals to instantly detect complications and provide the required treatment
  • BioImpact secured the rights from GPX Medical AB, which expects to obtain CE approval for NEOLA in 2023
  • Pending CE approval, BTC Health will begin the registration process allowing NEOLA to commercially launch in Australia and New Zealand
  • BTC Health spiked over 100 per cent earlier today but is now up just 11.25 per cent to trade at 8.9 cents per share
Previous article
AccountsIQ: Raises €5.8M in Funding
Next article
Superloop: Wins $25M contract with MNF Group’s Symbio
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Italy Fines Revolut €1.15M for Regulatory Violations

Revolut faces penalties due to non-compliance with Italian financial regulations.Highlights: Italy fines Revolut €1.15 million for regulatory breaches.The...
FinTech

DeFi Platform Drift Suspends Withdrawals After Crypto Hack

Drift takes precautionary measures following security breach affecting user funds.Highlights: Drift has suspended all deposits and withdrawals after...
FinTech

Cross River Bank Raises $50 Million to Accelerate Growth

The funding will enhance Cross River Bank's financial technology services.Highlights: Cross River Bank has raised $50 million in...
FinTech

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...